UDK: 615:547.785.5:616.24-005.6-092.4
A.A. Spasov1, A.F. Kucheryavenko1, A.V. Smirnov1, K.A. Gaidukova1, V.S. Sirotenko1, N.G. Panshin1, O.N. Zhukovskaya2
1ФГБОУ ВО «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации; 2НИИ Физической и органической химии Южного федерального университета
In this study, the antithrombotic activity of a new chemical compound of a benzimidazole derivative, which has a shielded phenolic substituent in its structure, under the laboratory code RU-1144 was studied, which exhibits high antiplatelet and antioxidant activity in vitro and in vivo tests. It was shown that the test sample has a pronounced antithrombotic effect and is superior in activity to the comparison drugs acetylsalicylic acid and clopidogrel in a model of cell thrombosis generated in mice.
arterial thrombosis, platelet aggregation, lipid peroxidation, compound RU-1144, acetylsalicylic acid, clopidogrel.
Гайдукова Ксения Андреевна – ассистент кафедры фармакологии и биоинформатики, Волгоградский государственный медицинский университет, e-mail: ksenijagajjdukva@rambler.ru